| Entry |
|
|---|
| Name |
Loracarbef (USP);
Loracarbef monohydrate;
LCBF;
Lorabid (TN)
|
|---|
| Formula |
C16H16ClN3O4. H2O
|
|---|
| Exact mass |
367.0935
|
|---|
| Mol weight |
367.7842
|
|---|
| Structure |
     |
|---|
| Activity |
Antibacterial
|
|---|
| Remark |
|
|---|
| Target |
penicillin binding proteins inhibitor |
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
| Cephalosporins - oral agents |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01D OTHER BETA-LACTAM ANTIBACTERIALS
J01DC Second-generation cephalosporins
J01DC08 Loracarbef
D00916 Loracarbef (USP)
Antiinfectives [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor
Penicillin binding proteins inhibitor
Cephems - Cephalosporins
Loracarbef [ATC:J01DC08]
D00916 Loracarbef (USP)
 |
|---|
| Other DBs |
CAS: 121961-22-6 PubChem: DrugBank: LigandBox: |
|---|
| KCF data |
ATOM 25
1 N1y N 28.1934 -19.4311
2 C1y C 28.1934 -18.0247
3 C5x C 26.7870 -19.4311
4 C2y C 29.4073 -20.1373
5 C1y C 26.7870 -18.0247
6 C1x C 29.4073 -17.3302
7 O5x O 25.7891 -20.4232
8 C2y C 30.6153 -19.4311
9 C6a C 29.4073 -21.5320
10 N1b N 25.5790 -17.3361
11 C1x C 30.6153 -18.0247
12 X Cl 31.8234 -20.1373
13 O6a O 28.1934 -22.2206
14 O6a O 30.6094 -22.2206
15 C5a C 24.3653 -18.0364
16 C1c C 23.1513 -17.3419
17 O5a O 24.3593 -19.4370
18 C8y C 21.9433 -18.0422
19 N1a N 23.1456 -15.9412
20 C8x C 21.9433 -19.4428
21 C8x C 20.7296 -17.3419
22 C8x C 20.7296 -20.1490
23 C8x C 19.5216 -18.0422
24 C8x C 19.5216 -19.4428
25 O0 O 33.7483 -17.6628
BOND 26
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 2
7 4 8 2
8 4 9 1
9 5 10 1
10 6 11 1
11 8 12 1
12 9 13 1
13 9 14 2
14 10 15 1
15 15 16 1
16 15 17 2
17 16 18 1
18 16 19 1 #Up
19 18 20 1
20 18 21 2
21 20 22 2
22 21 23 1
23 22 24 1
24 3 5 1
25 8 11 1
26 23 24 2
|
|---|
